A Prospective, Single-Arm,Multicenter Clinical Study of Orelabrutinib in Combination with Pola-R-miniCHP (OPR-miniCHP) for the Treatment of Previously Untreated Older Adults with High-Risk Diffuse Large B-Cell Lymphoma (ChiCTR) - Oct 16, 2026 - P4 | N=30 | Not yet recruiting | Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University; The First Affiliated Hospital, College of Medicine, Zhejiang University
New P4 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|